Ziphius

Ziphius

www.ziphius.org

hendrik.thys@ziphius.org

+32 472 41 80 91

Heidestraat 19

9820 Merelbeke

BE

Ziphius

Foundation date

10/07/2020

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Ziphius Vaccines is a global biopharmaceutical company dedicated to develop next-generation vaccines for the prevention of infectious diseases. We concentrate on a new class of vaccines, the messenger RNA or mRNA-based vaccines. More specifically, Ziphius focusses on self-amplifying mRNA-based vaccine. 

Upcoming events

Latest news

  • V-Bio Ventures leads €20 million Series A financing of Precision oncology company Flindr Therapeutics to advance first-in-class small molecule inhibitors

    Wednesday April 24th 2024

  • Labconsort and NEKTARI join forces for a more sustainable and social industry

    Saturday April 20th 2024

  • BIO INX Complements Advisory Board with Distinguished Industry Leaders

    Thursday April 18th 2024

Jobs by Ziphius

More info?

Contact us

Ellen Telleir

Communication Coordinator